Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus?

INTRODUCTION: Heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) bacteremia may result in clinical failure of vancomycin therapy, together with prolonged infection and hospitalization. This clinical problem has resulted in a search for more effective treatment options. The current...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakthavatchalam, Yamuna Devi, Ralph, Ravikar, Veeraraghavan, Balaji, Babu, Priyanka, Munusamy, Elakkiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374240/
https://www.ncbi.nlm.nih.gov/pubmed/30460607
http://dx.doi.org/10.1007/s40121-018-0224-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374240/
https://www.ncbi.nlm.nih.gov/pubmed/30460607
http://dx.doi.org/10.1007/s40121-018-0224-z

Ejemplares similares